1. Home
  2. SION
  3. SION News

Latest SIONNA THERAPEUTICS INC (SION) News on August 2, 2025

Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model
SION

GlobeNewswire

2 months ago

Sionna Therapeutics Announces Presentation of Preclinical Data that Demonstrate Proprietary Dual Combination Therapies Enable Full CFTR Correction in CFHBE Model

Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial
SION

Benzinga

2 months ago

Newly-Listed Sionna Therapeutics Touts Positive Data From Lung Disease Candidate In Healthy Volunteer Trial

Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis
SION

GlobeNewswire

2 months ago

Sionna Therapeutics Announces Positive Phase 1 Data for NBD1 Stabilizers SION-719 and SION-451 and Advances Both Programs in Clinical Development for Cystic Fibrosis

Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
SION

GlobeNewswire

2 months ago

Sionna Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference
SION

GlobeNewswire

2 months ago

Sionna Therapeutics to Present Preclinical Data During Oral Session at the 48th European Cystic Fibrosis Conference

Sionna Therapeutics Reports First Quarter 2025 Financial Results
SION

GlobeNewswire

3 months ago

Sionna Therapeutics Reports First Quarter 2025 Financial Results

While individual investors own 26% of Sionna Therapeutics, Inc. (NASDAQ:SION), private equity firms are its largest shareholders with 56% ownership
SION

Simply Wall St.

3 months ago

While individual investors own 26% of Sionna Therapeutics, Inc. (NASDAQ:SION), private equity firms are its largest shareholders with 56% ownership

Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025
SION

GlobeNewswire

3 months ago

Sionna Therapeutics to Present at The Citizens Life Sciences Conference 2025

SION

MT Newswires

4 months ago

Top Premarket Decliners

SION

MT Newswires

4 months ago

Top Premarket Decliners

Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results
SION

GlobeNewswire

4 months ago

Sionna Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results

Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month
SION

Insider Monkey

5 months ago

Sionna Therapeutics, Inc. (SION): Among Top Insider Purchases Last Month

Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently?
SION

Insider Monkey

5 months ago

Is Sionna Therapeutics, Inc. (SION) Among Stocks With At Least $20 Million In Insider Spending Recently?

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently
SION

Insider Monkey

5 months ago

Sionna Therapeutics, Inc. (SION): Among Stocks With At Least $10 Million In Insider Spending Recently

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market
SION

Pharmaceutical Technology

5 months ago

Sionna Therapeutics’ IPO: A strategic shift in the cystic fibrosis market

Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference
SION

GlobeNewswire

5 months ago

Sionna Therapeutics to Present at the 45th Annual TD Cowen Health Care Conference

Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?
SION

Insider Monkey

5 months ago

Is Sionna Therapeutics (SION) Among Stocks Insiders Are Buying This Year?

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
SION

GlobeNewswire

6 months ago

Sionna Therapeutics Announces Closing of $219.2 million Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Share on Social Networks: